Online citations, reference lists, and bibliographies.

Does This Patient Have Pheochromocytoma? A Systematic Review Of Clinical Signs And Symptoms

A. Soltani, M. Pourian, Babak Mostafazadeh Davani
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ContextPheochromocytoma is a rare disease but with high mortality if it is not being diagnosed early. Several biochemical tests with high accuracy have been obtained, but the clinical threshold for request of these tests is not determined clearly.ObjectivesTo determine the Likelihood Ratios of clinical symptoms and signs in diagnosing pheochromocytoma. And also meta-analysis of their sensitivity in this disease.Data sourcesMEDLINE was searched for relevant English-language articles dated 1960 to February 2014. Bibliographies were searched to find additional articles.Study selectionWe included original studies describing the sensitivity and/or likelihood ratios of signs and symptoms in clinical suspicion of pheochromocytoma. Their method of diagnosis should have been based on pathology. We excluded specific subtypes or syndromes related to pheochromocytoma, or specific ages or gender. Also we excluded studies before 1993 (JNC5) which no definition of hypertension was presented. 37 articles were chosen finally.Data extractionTwo authors reviewed data from articles independently and gave discrepancies to third author for decision. The aim was extraction of raw numbers of patients having defined signs or symptoms, and draw 2 × 2 tables if data available. We meta-analyzed sensitivities by Statsdirect and Likelihood Ratios by Meta-disc soft wares. Because our data was heterogeneous based on I2 > 50 % (except negative Likelihood ratio of hypertension), we used random effect model for doing meta-analysis. We checked publication bias by drawing Funnel plot for each sign/symptom, and also Egger test.Data synthesisThe most prevalent signs and symptoms reported were hypertension (pooled sensitivity of 80.7 %), headache (pooled sensitivity of 60.4 %), palpitation (pooled sensitivity of 59.3 %) and diaphoresis (pooled sensitivity of 52.4 %). The definition of orthostatic hypotension was different among studies. The sensitivity was 23–50 %.Paroxysmal hypertension, chest pain, flushing, and weakness were the signs/symptoms which had publication bias based on Funnel plot and Egger test (P value < 0.05). Seven of the articles had control group, and could be used for calculating LR of signs/symptoms. Diaphoresis (LR+ 2.2, LR-0.45), Palpitation (LR+ 1.9, LR-0.52) and headache (LR+ 1.6, LR-0.24) were significant symptoms in clinical diagnosis of pheochromocytoma. Other signs and symptoms had been reported in only one study and could not have been meta-analyzed. Classic triad of headache, palpitation and diaphoresis in hypertensive patients had the LR+ 6.312 (95 % CI 0.217–183.217) and LR-0.139 (95 % CI 0.059–0.331). Surprisingly, hypertension was not important in clinical suspicion of pheochromocytoma, and even normotension increased the probability of the disease.ConclusionsBy available data, there is no single clinical finding that has significant value in diagnosis or excluding pheochromocytoma. Combination of certain symptoms, signs and para-clinical exams is more valuable for physicians. Further studies should be done, to specify the value of clinical findings.Until that time the process of diagnosis will be based on clinical suspicion and lab tests followed by related imaging.
This paper references
10.1080/10253890701395896
Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice
T. Zelinka (2007)
10.1001/archinte.1993.00410020010002
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
(1993)
10.1530/EJE.0.1410619
Pheochromocytoma in Italy: a multicentric retrospective study.
M. Mannelli (1999)
10.1016/S0022-5347(17)53807-0
Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.
M. G. Sutton (1981)
10.1002/ejs.6161681210
25 years experience of the surgical treatment of phaeochromocytoma.
U. Niemann (2002)
10.1530/EJE.0.1500681
Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients.
J. Baguet (2004)
10.1634/theoncologist.2008-0043
Pheochromocytoma: current approaches and future directions.
J. Adler (2008)
10.1016/j.nucmedbio.2008.04.007
A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.
I. Ilias (2008)
Ann Surg
(1990)
10.1093/qjmed/90.1.51
Phaeochromocytoma: a ten-year survey.
K. Loh (1997)
10.1007/s12020-008-9108-4
Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma
E. W. Lai (2008)
A clinico-pathological study on pheochromocytoma at the University Hospital of the West Indies
C Charles (1984)
10.1001/archneur.1976.00500040065011
Symptoms of pheochromocytoma, with particular reference to headache, correlated with catecholamine production.
J. Lance (1976)
Phaeochromocytoma in the Hong Kong Chinese population.
J. Y. Yau (2010)
10.1016/S0025-7125(16)30088-8
Pheochromocytoma. Update on diagnosis, localization, and management.
S. Werbel (1995)
10.1016/S0987-7053(99)80055-0
Harrison's principles of internal medicine
J. M. Guérit (1999)
10.1097/00008469-200410000-00008
Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre
A. Patócs (2004)
10.1097/HJH.0b013e32813aeb5a
Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients
J. Václavík (2007)
10.1530/EJE-10-0114
Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms.
Nicolette van Duinen (2010)
47 years of phaeochromocytomas.
T. O'Halloran (2001)
Pheochromocytoma: a 10-year experience in a tertiary care North Indian hospital.
N. Sharma (2001)
10.1097/00000658-199011000-00010
Surgical management of pheochromocytoma with the use of metyrosine.
R. Perry (1990)
10.1016/S0895-7061(99)00139-9
Changes in clinical features and long-term prognosis in patients with pheochromocytoma.
T. Noshiro (2000)
10.3126/KUMJ.V10I3.8020
Phaeochromocytoma in Nepal--a single centre experience.
P. Maskey (2012)
10.1097/00000658-199906000-00001
Clinical experience over 48 years with pheochromocytoma.
R. Goldstein (1999)
10.1210/JC.2004-1398
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.
L. Amar (2005)
10.1507/ENDOCRJ.48.151
Clinical differences between benign and malignant pheochromocytomas.
B. Glodny (2001)
Pheochromocytoma: a twenty year experience at the University Hospital.
F. Aguiló (1991)
10.1530/EJE-09-0384
Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma.
Robert Kopetschke (2009)
10.1007/s002689900454
Pheochromocytoma, a Rare Cause of Hypertension: Long-term Follow-up of 55 Surgically Treated Patients
G. Favia (1998)
10.1111/J.0954-6820.1988.TB15883.X
Long-term results in 64 patients operated upon for pheochromocytoma.
G. Stenström (1988)
10.1001/jama.1966.03110100062014
The neurologist's experience with pheochromocytoma. A review of 100 cases.
J. Thomas (1966)
Pheochromocytoma--recent advances in diagnosis and treatment.
Neal L. Benowitz (1988)
10.1002/9780470692196.CH4
Clinical Presentation of Pheochromocytoma
K. Pacak (2008)
[Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)].
P. Plouin (1981)
10.1055/s-0029-1237699
False positive test results for pheochromocytoma from 2000 to 2008.
R. Yu (2010)
10.1097/CRD.0000000000000141
Cardiovascular Manifestations of Pheochromocytoma
Yu Gu (2017)
10.1016/S0009-9120(00)00172-7
A five-year report on experience in the detection of pheochromocytoma.
F. C. Hernández (2000)
10.1016/S0002-9610(00)00296-8
Adrenal pheochromocytoma remains a frequently overlooked diagnosis.
C. Lo (2000)
10.1161/01.HYP.29.5.1133
Tumor recurrence and hypertension persistence after successful pheochromocytoma operation.
P. Plouin (1997)
10.1007/BF00353738
“The” pheochromocytoma: A benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist?
C. Proye (1994)
A clinical scoring system for detection of patients with pheochromocytomas.
H. Black (1984)
10.1097/00005792-199101000-00004
A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience.
P. Stein (1991)
Recent developments in pheochromocytoma diagnosis and imaging.
P. Plouin (1988)
10.1016/S0140-6736(15)00108-7
Lancet
B. Bynum (2015)
10.1016/j.amjmed.2008.08.021
Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007.
R. Yu (2009)
10.1111/J.1365-2796.2005.01504.X
Long-term outcome of a large series of patients surgically treated for pheochromocytoma.
A. Khorram-Manesh (2005)
Pheochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results
Im Modlin (1979)
Marston Linehan Pheochromocytoma: evaluation, diagnosis, and treatment
M Mcclellan (1999)
10.1007/s003450050102
Pheochromocytoma: evaluation, diagnosis, and treatment
M. Walther (1999)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar